Global In-Vitro Fertilization Services Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

 In-Vitro Fertilization Services Market Size

• The global in-vitro fertilization services market size was valued at USD 28.1 billion in 2024 and is expected to reach USD 65.03 billion by 2032, at a CAGR of 11.06% during the forecast period
• This growth is driven by factors such as the rising infertility rates, increasing adoption of assisted reproductive technologies, and favorable regulatory support across developing and developed countries

In-Vitro Fertilization Services Market Analysis

• In-vitro fertilization (IVF) services are advanced assisted reproductive technologies (ART) used to address infertility issues by enabling fertilization outside the human body, followed by embryo transfer into the uterus. IVF is widely used for individuals and couples facing infertility, genetic disorders, or age-related fertility decline
• The demand for IVF services is significantly driven by the increasing infertility rates globally, delayed parenthood trends, and growing success rates due to technological advancements such as time-lapse imaging, preimplantation genetic testing (PGT), and AI in embryo selection
• Asia-Pacific is experiencing significant growth in the In-Vitro Fertilization (IVF) Services Market, accounting for around 20% of the global market share. This growth is fueled by increasing awareness, improving healthcare infrastructure, and a rising demand for fertility treatments
• Europe is projected to maintain a strong position in the In-Vitro Fertilization (IVF) Services Market, accounting for around 28% of the global market share, driven by a well-established healthcare system and high awareness of fertility treatments.
• The fresh non-donor segment is expected to dominate the IVF services market, holding a market share of approximately 38% in 2024, due to its higher success rates and widespread use in fertility clinics. However, frozen embryo transfers and donor egg IVF cycles are rapidly gaining momentum, driven by improved cryopreservation techniques and evolving family planning choices

Report Scope and In-Vitro Fertilization Services Market Segmentation         

In-Vitro Fertilization Services Market Trends

“Advancements in IVF Technology and Genetic Testing for Enhanced Success Rates”

• One prominent trend in the IVF services market is the increasing integration of advanced genetic testing and AI-based embryo selection systems to improve success rates and reduce the likelihood of genetic disorders
• Technologies such as Preimplantation Genetic Testing (PGT) allow for the screening of embryos for genetic disorders before implantation, significantly improving the chances of a healthy pregnancy and reducing the risk of inherited conditions. This is particularly beneficial for older women and couples with a family history of genetic diseases

• For instance, AI algorithms are now being employed to analyze embryos and predict their viability with higher accuracy. These AI-based systems assess factors such as embryo morphology and development patterns, assisting clinicians in selecting the best embryos for transfer

• These advancements are transforming the IVF process, enhancing pregnancy outcomes, reducing costs associated with multiple IVF cycles, and driving the demand for high-tech IVF clinics equipped with the latest genetic testing and embryo screening technologies 

In-Vitro Fertilization Services Market Dynamics

Driver

“Growing Need Due to Rising Infertility Rates and Delayed Parenthood”

• The rising infertility rates and the increasing trend of delayed parenthood are significantly contributing to the growing demand for in-vitro fertilization (IVF) services
• As many individuals and couples delay having children due to career, lifestyle, and educational reasons, the age-related decline in fertility is becoming more prominent. This has led to an increase in the number of people seeking ART (Assisted Reproductive Technologies) such as IVF to achieve pregnancy later in life
• Older women, especially those over 35 years of age, are more likely to face infertility issues, prompting them to seek IVF services. The use of IVF helps in overcoming issues such as poor egg quality, low sperm count, and other age-related infertility concerns

For instance,

• In March 2023, the American Society for Reproductive Medicine (ASRM) reported that the average age of women seeking IVF treatments in the U.S. has increased, with nearly 40% of IVF cycles being initiated by women aged 35 and older. This reflects the growing trend of delayed parenthood and the corresponding increase in demand for fertility services

• The growing prevalence of infertility across various age groups, coupled with the increasing acceptance of ART, is leading to a substantial rise in the demand for IVF services, ensuring more couples and individuals have access to successful fertility treatments

Opportunity

“Expansion of Fertility Clinics and Increasing Accessibility to IVF Services”

• The growing number of fertility clinics worldwide presents a significant opportunity for the IVF services market. As more specialized clinics open up, they bring advanced IVF technologies and services to both urban and rural areas, making treatments more accessible to a wider population
• Fertility clinics are not only increasing in number but also enhancing their services by incorporating cutting-edge technologies, personalized care models, and expanding multi-cycle IVF offerings to improve success rates
• The global demand for IVF services is driving the expansion of IVF clinics into emerging markets, particularly in regions like Africa, Latin America, and Eastern Europe, where awareness of assisted reproductive technologies (ART) is growing. The availability of more local options for IVF treatment is expected to reduce costs and improve accessibility

For instance,

• In January 2024, Clinica Tambre in Spain expanded its network of IVF clinics across Latin America, opening new centers in Colombia and Mexico to provide affordable, high-quality fertility treatments. The clinic’s expansion is an effort to meet the growing demand for ART services in the region, where infertility awareness is rising

• The increased availability of fertility services in more regions is creating an opportunity to improve access for underserved populations, reducing the financial and logistical barriers associated with seeking IVF treatments abroad

Restraint/Challenge

“High Treatment Costs Hindering Accessibility and Market Growth”

• The high cost of in-vitro fertilization (IVF) services remains a significant challenge for the market, particularly affecting the accessibility of these services for a wide range of patients, especially in developing countries
• IVF treatments often involve multiple cycles, genetic testing, embryo freezing, and medication, which can result in significant costs. In some regions, a single IVF cycle can range from USD 5,000 to USD 20,000, depending on the location and complexity of the treatment
• This financial barrier prevents many individuals and couples, particularly those without adequate insurance coverage, from accessing IVF services, leading to disparities in treatment availability between socioeconomic groups and regions

For instance,

• In December 2024, a report published by the World Health Organization highlighted the cost barrier to IVF access in developing countries. The report noted that the high cost of IVF is a key factor limiting its availability in countries such as India, Brazil, and South Africa, where the average cost of a single IVF cycle can be up to USD 10,000, which is unaffordable for a large segment of the population

• As a result, many patients in these regions may need to seek alternative or less advanced treatment options, which can limit the overall growth of the IVF market in those areas and hinder the adoption of newer technologies

In-Vitro Fertilization Services Market Scope

The market is segmented on the basis type of cycles and end users.

In 2025, the fresh non-donor is projected to dominate the market with a largest share in application segment

In 2025, the fresh non-donor segment is projected to dominate the In-Vitro Fertilization (IVF) Services Market, accounting for around 60% of the global market share. This dominance is driven by its higher success rates and widespread use in fertility clinics. As the preferred treatment method, fresh non-donor IVF cycles offer more favorable outcomes compared to frozen embryo transfers or donor egg cycles. North America is expected to lead the market with 45% share, followed by Asia-Pacific, where demand for cost-effective IVF treatments is growing rapidly, contributing to the segment's market growth.

The fertility clinics is expected to account for the largest share during the forecast period in product type segment

In 2025, the fertility clinics and surgical centres segment is expected to dominate the global In-Vitro Fertilization (IVF) Services Market, accounting for around 40% of the global share. North America will lead this segment with approximately 45%, followed by Europe at 30%. The Hospital and Research Laboratories segment will grow steadily, with Asia-Pacific projected to see the fastest growth, contributing around 25% to the market. Cryobanks are also anticipated to expand, with North America and Europe leading, accounting for 50% of the market share due to increased fertility preservation demand and advanced cryopreservation technologies.

In-Vitro Fertilization Services Market Regional Analysis

“Asia-Pacific Holds the Largest Share in the In-Vitro Fertilization Services Market”

• Asia-Pacific is experiencing significant growth in the In-Vitro Fertilization (IVF) Services Market, accounting for around 20% of the global market share. This growth is fueled by increasing awareness, improving healthcare infrastructure, and a rising demand for fertility treatments
• Countries like China, India, and Japan are leading the market, driven by high infertility rates and growing adoption of Assisted Reproductive Technologies (ART), including IVF
• The region benefits from improving access to fertility clinics and government policies supporting ART, making IVF treatments more affordable and accessible
• Technological advancements and increasing investments in fertility research are also driving the rapid expansion of IVF services in Asia-Pacific

“Europe is Projected to Register the Highest CAGR in the In-Vitro Fertilization Services Market”

• Europe is projected to maintain a strong position in the In-Vitro Fertilization (IVF) Services Market, accounting for around 28% of the global market share, driven by a well-established healthcare system and high awareness of fertility treatments
•  Countries like the UK, Germany, and France lead the market due to extensive fertility clinics, advanced ART technologies, and government-supported policies that enhance accessibility
• Increasing demand for IVF services is further fueled by favorable reimbursement policies, growing public acceptance, and continuous innovations in ART, which have improved treatment outcomes and success rates in the region
• As a result, Europe remains a key player, attracting both regional and international investments in the IVF market

In-Vitro Fertilization Services Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• IVF Worldwide (Israel)
• Merck KGaA (Germany)
• Sanno Hospital (Japan)
• BIOART Fertility Clinic (South Africa)
• Durban Fertility Clinic (South Africa)
• Cape Fertility Clinic (South Africa)
• Ambroise Paré Clinic (France)
• A CooperSurgical Fertility Company (U.S.)
• Scanfert Clinic (Finland)
• Bangkok IVF Center (Thailand)
• Bangkok Hospital (Thailand)
• Advanced Reproductive Care (U.S.)
• BFC Forex & Financial Services Pvt. Ltd. (India)
• CARDONE Industries (U.S.)
• CHA Fertility Center (U.S.)
• Cloudninecare.com (Cloudnine Fertility) (India)
• Conceptions Reproductive Associates of Colorado (U.S.)
• Gaudium IVF & Gynae Solutions (India)
• EQT AB (Sweden)
• EUVITRO S.L.U. (Spain)
• Genea Limited (Australia)
• ICRM (Idaho Center for Reproductive Medicine) (U.S.)
• Panama Fertility (Panama)
• KL FERTILITY CENTRE (Malaysia)
• Monash IVF Australia (Australia)
• RAPRUI S.r.l. (Italy)
• SAFE FERTILITY CENTER (Thailand)
• IVFGA.COM (India)
• Southend Fertility and IVF (India)

Latest Developments in Global In-Vitro Fertilization Services Market

• In December 2024, Gameto, a biotechnology company focused on women's reproductive health, partnered with IVFAustralia (IVFA), an Australian IVF clinic chain under Virtus Health. This collaboration introduces Gameto's innovative product, Fertilo, to select IVFA/Virtus clinics. Fertilo, designed to enhance IVF and egg freezing processes, uses induced pluripotent stem cells (iPSCs) to mature eggs outside the body, reducing hormone injections by 80% and minimizing side effects. The partnership aims to improve patient experiences and outcomes in fertility treatments 
• In September 2024, MGM Healthcare introduced its advanced In-Vitro Fertilization (IVF) services through the newly launched Varam IVF Centre. Located at MGM Healthcare in Chennai, this state-of-the-art facility combines cutting-edge technology with personalized care to offer comprehensive fertility treatments. The center brings together experienced specialists and extensive ancillary services under one roof, aiming to support couples facing infertility challenges. Varam IVF provides a range of services, including ovarian stimulation, IUI, IVF, and genetic testing, ensuring tailored care for each patient
• In May 2024, Gameto, a female-led biotechnology company dedicated to transforming women's healthcare, unveiled new data showcasing the clinical-grade manufacturing of its innovative in vitro maturation (IVM) solution, Fertilo. This investigational product utilizes engineered ovarian support cells (OSCs) to mature eggs outside the body, offering a groundbreaking approach to fertility care. The research highlights advanced cellular engineering and manufacturing techniques, emphasizing Fertilo's potential to enhance IVF outcomes while reducing hormone stimulation. Gameto's commitment to redefining reproductive health is evident in its strategic development of Fertilo  
• In February 2024, the Maharashtra government introduced a transformative initiative to provide free in vitro fertilization (IVF) treatments at government-run medical colleges and hospitals (GMCH). Previously costing over USD 2,400 (RS 2 lakh) per cycle in private clinics, these treatments are now accessible at no cost, easing the financial burden for thousands of couples facing infertility. The state allocated significant funding to equip GMCHs with advanced infrastructure and expertise, ensuring high-quality care. This initiative represents a major step forward in public healthcare and underscores Maharashtra's dedication to reproductive health   
• In January 2024, ReproTech introduced Cryo-Logix, a specialized entity offering a seamless, end-to-end cryostorage solution for in vitro fertilization (IVF) clinics. Operating independently under ReproTech, Cryo-Logix aims to enhance patient care from consent to disposition. Its team addresses administrative challenges faced by IVF clinics by managing billing, collections, patient outreach, logistics, and cryogenic inventory disposition, whether stored at the clinic or ReproTech facilities. This initiative ensures streamlined operations and improved patient experiences  

SKU-40950